On this page
CHRNE
cholinergic receptor nicotinic epsilon subunit
The CHRNE gene provides instructions for producing a key component of the acetylcholine receptor (AChR) protein, essential for nerve-to-muscle communication. CHRNE encodes the epsilon subunit of the acetylcholine receptor, which plays a critical role in signalling at the neuromuscular junction.
CHRNE is located on the short (p) arm of chromosome 17, at band 17p13.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 17 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The CHRNE gene, also known as cholinergic receptor nicotinic epsilon subunit, is crucial for proper muscle function. It provides genetic instructions for one of the five subunits that form the acetylcholine receptor (AChR) protein, an ion channel vital for transmitting signals between nerves and muscles.
Dysfunction of the CHRNE gene can disrupt this communication, leading to conditions characterised by muscle weakness and fatigue, such as congenital myasthenic syndromes. Understanding CHRNE is important for diagnosing and managing these inherited neuromuscular disorders.
What the gene does
The CHRNE gene produces the epsilon (ε) subunit, which is an integral part of the adult-type acetylcholine receptor (AChR) protein. The AChR is a pentameric protein, meaning it is assembled from five subunits, and is located on the surface of skeletal muscle cells. These receptors are concentrated at the neuromuscular junction, the specialised synapse where nerve cells transmit signals to muscle cells to initiate movement.
Within the endoplasmic reticulum, the five subunits of the AChR protein assemble. The epsilon subunit specifically replaces the gamma subunit around the 33rd week of pregnancy, forming the mature adult AChR. Once assembled, the AChR protein is transported to the muscle cell surface. When acetylcholine, a neurotransmitter, binds to the AChR, it causes an ion channel to open, leading to muscle contraction. Proper functioning of the epsilon subunit is therefore essential for effective nerve-muscle signalling and normal voluntary movement.
Video: Genetics 101
Chromosome location
The CHRNE gene is located on chromosome 17, specifically at position 17p13.2. This region denotes the short (p) arm of chromosome 17, band 13.2. The gene directs the synthesis of a protein comprising 493 amino acids.
Protein structure
The CHRNE gene encodes the epsilon subunit of the acetylcholine receptor. Domain architecture has not been experimentally characterised in detail for this protein.
Key variants
Variants within the CHRNE gene can alter the structure or function of the epsilon subunit, leading to impaired acetylcholine receptor function. These genetic changes can affect the assembly, stability, or activity of the receptor, consequently disrupting nerve-to-muscle signal transmission. Such variants are typically inherited in an autosomal recessive pattern.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1002_1008dup | p.Ala337fs | Pathogenic | ★★☆☆ | Congenital myasthenic syndrome |
c.1016_1032+2dup | - | Pathogenic/Likely pathogenic | ★★☆☆ | Congenital myasthenic syndrome 4B |
c.1116_1128del | p.Ser373fs | Pathogenic/Likely pathogenic | ★★☆☆ | Congenital myasthenic syndrome |
c.1248_1266dup | p.Cys423fs | Pathogenic | ★★☆☆ | Congenital myasthenic syndrome 4A |
c.1251_1266dup | p.Cys423fs | Pathogenic/Likely pathogenic | ★★☆☆ | Congenital myasthenic syndrome |
c.1255G>T | p.Glu419Ter | Pathogenic | ★★☆☆ | Congenital myasthenic syndrome 4A |
c.1258del | p.Val420fs | Pathogenic/Likely pathogenic | ★★☆☆ | Congenital myasthenic syndrome |
c.1379G>A | p.Trp460Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Congenital myasthenic syndrome 4A |
c.1381_1390del | p.Ala461fs | Pathogenic/Likely pathogenic | ★★☆☆ | Congenital myasthenic syndrome 4B |
c.1383_1393del | p.Ala462fs | Pathogenic/Likely pathogenic | ★★☆☆ | Congenital myasthenic syndrome 4A |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the CHRNE gene are primarily associated with congenital myasthenic syndromes. These are a group of rare inherited disorders characterised by muscle weakness and fatigue, often beginning in infancy or early childhood. The severity and presentation of symptoms can vary among affected individuals.
- Congenital myasthenic syndromes Dedicated page coming soon
Inheritance pattern
Conditions caused by pathogenic CHRNE variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
The CHRNE gene is recognised within the NHS Genomic Medicine Service. It is listed on several green-rated PanelApp panels, including those for Arthrogryposis (R83), Congenital myaesthenic syndrome (R80), and Foetal anomalies (R21), indicating strong evidence for its association with these conditions and its inclusion in routine clinical genetic testing for relevant patients.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the CHRNE gene responsible for?
The CHRNE gene provides instructions for making the epsilon subunit, a key component of the adult-type acetylcholine receptor protein. This receptor is vital for transmitting signals from nerves to muscles, enabling movement.
What are congenital myasthenic syndromes?
Congenital myasthenic syndromes are a group of inherited conditions characterised by muscle weakness and easy fatigability. They result from impaired communication between nerves and muscles, often due to genetic changes in genes like CHRNE.
How are CHRNE-related conditions inherited?
Conditions caused by variants in the CHRNE gene are typically inherited in an autosomal recessive pattern. This means an individual must inherit two copies of the altered gene (one from each parent) to develop the condition.